ENTPD1 and neoplasm: In this regard, it is interesting to note that CD39+ tumor-infiltrating Treg in our patient cohort express more Foxp3 on a per cell basis than CD39− Treg, suggestive of a more immunosuppressive effector Treg subset associated with poor patient outcome.